There isn't one single "new" treatment for multiple sclerosis (MS). Instead, researchers are constantly developing new approaches and improving existing therapies.
Here are some examples of recent advancements in MS treatment:
New Medications
- Ocrelizumab (Ocrevus): This is a monoclonal antibody that targets specific immune cells that attack the myelin sheath in the brain and spinal cord. It's approved for both relapsing-remitting MS and primary progressive MS.
- Siponimod (Mayzent): This oral medication targets specific immune cells and is approved for the treatment of secondary progressive MS and active relapsing-remitting MS.
- Ofatumumab (Kesimpta): Another monoclonal antibody, Ofatumumab targets B cells, a type of immune cell that plays a role in the development of MS. It's approved for relapsing forms of MS.
- Cladribine tablets (Mavenclad): This oral medication is a disease-modifying therapy that works by reducing the number of immune cells that attack the nervous system. It's approved for relapsing forms of MS.
Emerging Therapies
- Stem cell therapy: This involves transplanting healthy stem cells to replace damaged cells in the nervous system. It's currently in clinical trials for MS.
- Gene therapy: Researchers are exploring ways to use gene therapy to modify the immune system or repair damaged myelin.
- Immunomodulatory therapies: These therapies aim to modulate the immune system to reduce inflammation and prevent further damage.
It's important to note that the best treatment for MS depends on the individual's specific needs and disease progression. Always consult with a neurologist or other qualified healthcare professional for personalized advice and treatment recommendations.
